We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




FDA Warns Against Thermography Breast Cancer Detection

By MedImaging International staff writers
Posted on 11 Mar 2019
Print article
Thermography should not be used as an alternative to mammography for breast cancer screening or diagnosis, warns the US Food and Drug Administration (FDA; Silver Spring, MD, USA).

The FDA safety communication was issued to alert women, health care providers, and those wishing to undergo breast cancer screening that thermography is not an effective alternative to mammography, and should not be used in place of mammography for breast cancer screening or diagnosis. The safety communication followed a warning letter issued on February 22, 2019, to Total Thermal Imaging (La Mesa, CA, USA) for marketing and promoting thermography devices for uses that have not received marketing clearance or approval.

The FDA clarified that thermography devices, also known as digital infrared (IR) imaging devices, have been cleared for marketing only for use with another screening or diagnostic test like mammography, and not for use as a standalone diagnostic tool, and that there is no valid scientific data to demonstrate that thermography devices are an effective screening tool for any medical condition, including the early detection of breast cancer or other diseases and health conditions. Thermography is not a substitute for regular mammograms, and should not be used in place of mammography for breast cancer screening or diagnosis.

The FDA also issued several recommendations for health care providers, including that they educate patients about the limitations of thermography, such as that the high false negative and false positive rates of thermography can provide misleading information that could result in a delayed diagnosis or unnecessary medical follow up. Providers should also discourage the use of thermography to diagnose or screen for breast cancer and talk to patients or caregivers about safe and effective ways to screen for breast cancer, including the benefits and risks of available testing options, clinical breast exams, and other breast imaging options such as ultrasound or MRI, or breast tissue biopsy.

“The FDA is aware that health spas, homeopathic clinics, mobile health units, and other health care facilities are using thermography inappropriately as a standalone tool for breast cancer screening or diagnosis,” stated the FDA. “These types of facilities provide false information that can mislead patients into believing that thermography can find breast cancer years before it would be detected through other methods or thermography improves detection of cancer in dense breasts.”

Thermography refers to digital infrared thermal imaging (DITI), a test that detects temperature changes on the surface of the skin using an IR thermal camera to record the areas of different temperature in the breasts. The camera displays these patterns as a heat map. As the presence of a tumor is associated with the excessive formation of blood vessels and inflammation in the breast tissue, the theory is that these changes should show up on the IR image as areas with a higher skin temperature.

Related Links:
Food and Drug Administration

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Color Doppler Ultrasound System
DRE Crystal 4PX
New
X-Ray Detector
FDR-D-EVO III
Digital Radiography Acquisition Software
VXvue with PureImpact

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.